Recombinant SSX2IP anticorps

N° du produit ABIN7882415

Cet anticorps anti-SSX2IP Monoclonal Lapin (Clone 30S65) (ABIN7882415) détecte spécifiquement SSX2IP dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant SSX2IP anticorps (ABIN7882415)

Antigène: SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp SSX2IP est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Clone: 30S65

Détail du produit anti-SSX2IP anticorps

Fonction: SSX2IP Antibody / Synovial sarcoma X breakpoint protein 2 interacting protein

Purification: Affinity-chromatography

Immunogène: A synthesized peptide derived from human SSX2IP was used as the immunogen for the SSX2IP antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the SSX2IP antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the SSX2IP antibody at -20oC.

Détails sur SSX2IP

Antigène: SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))

Autre désignation: SSX2IP

Sujet: SSX2IP antibody detects synovial sarcoma X breakpoint protein 2 interacting protein, a centrosomal protein involved in cell division and spindle organization. SSX2IP contributes to centrosome maturation and stability, facilitating accurate chromosome segregation. It has also been implicated in ciliogenesis, reflecting its role in microtubule-based processes beyond mitosis.

Research using SSX2IP antibody has linked the protein to cancer progression. Altered expression of SSX2IP has been observed in hematologic malignancies and solid tumors, where it may affect proliferation and genomic stability. SSX2IP also plays a role in cell adhesion and migration, adding to its importance in tumor biology. In developmental contexts, its regulation of ciliogenesis connects it to congenital disorders tied to defective ciliary signaling.

Antibodies against SSX2IP are applied in western blot, immunofluorescence, and immunohistochemistry. These reagents enable investigation of centrosome integrity, mitotic processes, and ciliary dynamics. Clone validation ensures reproducible results across research applications.

NSJ Bioreagents supplies this SSX2IP antibody for studies in cell cycle regulation, cancer biology, and ciliary function. Alternate names include synovial sarcoma X breakpoint protein 2 interacting protein antibody, AF-15q14 antibody, and centrosomal protein SSX2IP antibody.

UniProt: Q9Y2D8